title: Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel.
abstract: The effect of an antisense oligonucleotide to the K+ channel coding mKv1.1 mRNA on antinociception induced by the tricyclic antidepressants, clomipramine (20-35 mg kg(-1) s.c.) and amitriptyline (10-25 mg kg(-1) s.c.), was investigated in the mouse hot-plate test. Antisense oligonucleotide (0.5-1.0-2.0-3.0 nmol per i.c.v. injection) produced a dose-dependent inhibition of clomipramine and amitriptyline antinociception 72 h after the last i.c.v. injection. The sensitivity to both analgesic drugs returned 7 days after antisense oligonucleotide injection, indicating the absence of irreversible damage or toxicity. Treatment with a degenerated oligonucleotide did not modify the clomipramine- and amitriptyline-induced antinociception in comparison with that in naive (unpretreated controls), vector and saline i.c.v.-injected mice. A quantitative reverse transcription-polymerase chain reaction (RT-PCR) study demonstrated a reduction in mRNA levels only in the antisense oligonucleotide treated group. Antisense oligonucleotide, degenerated oligonucleotide or vector pretreatment, in the range of doses used, did not produce any behavioural impairment as revealed by the mouse rotarod and hole-board tests. The present results indicate that modulation of the mKv1.1 K+ channel plays an important role in the central analgesia induced by the tricyclic antidepressants, clomipramine and amitriptyline.
authors.affiliation: Department of Pharmacology, University of Florence, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Galeotti
authors.forename: C
authors.initials: C
authors.lastname: Ghelardini
authors.forename: S
authors.initials: S
authors.lastname: Capaccioli
authors.forename: A
authors.initials: A
authors.lastname: Quattrone
authors.forename: A
authors.initials: A
authors.lastname: Nicolin
authors.forename: A
authors.initials: A
authors.lastname: Bartolini
mesh_terms: D000639:Amitriptyline / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002997:Clomipramine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009043:Motor Activity / Q000187:drug effects; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects*; D016133:Polymerase Chain Reaction; D015221:Potassium Channels / Q000187:drug effects / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D017385:Sequence Homology; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: D016376:Oligonucleotides, Antisense; D015221:Potassium Channels; D012333:RNA, Messenger; D010566:Virulence Factors, Bordetella; D000639:Amitriptyline; D002997:Clomipramine